A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries

Vanja Radišić Biljak; Kristin Moberg Aakre; Dogan Yucel; Anne-Sophie Bargnoux; Jean-Paul Cristol; Laurence Piéroni

A Pathway to National Guidelines for Laboratory Diagnostics of Chronic Kidney Disease - Examples from Diverse European Countries

EJIFCC. 2017 Dec 19;28(4):289-301. eCollection 2017 Dec.

Authors

Vanja Radišić Biljak¹, Kristin Moberg Aakre², Dogan Yucel³, Anne-Sophie Bargnoux⁴, Jean-Paul Cristol⁴, Laurence Piéroni⁴

Affiliations

¹ Department of Medical Biochemistry and Laboratory Medicine, Merkur University Hospital, Zagreb, Croatia, on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM).
² Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway.
³ Department of Medical Biochemistry, Ankara Training and Research Hospital, University of Health Sciences, Altindag, Ankara and Turkish Biochemical Society.
⁴ Laboratoire de Biochimie, CHRU de Montpellier, PhyMedExp, University of Montpellier, France, on behalf of the Société Française de Biologie Clinique (SFBC).

PMID: 29333148
PMCID: PMC5746838

Abstract

The principal benefit of guidelines is to improve the quality of care received by patients. In the 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (KDIGO) was released and it is designed to provide information and assist decision making. This review gives a brief overview of a various national CKD guidelines that rely on the newly released KDIGO guidelines. All of the included countries (France, Turkey, Norway and Croatia) are non-English speaking countries and they differ in population and socio economic aspects. Examples shown in this review may provide valuable experience for countries that are in process of creating their national CKD guidelines.

Keywords: KDIGO; chronic kidney disease (CKD); laboratory medicine; national guidelines.